Picture of Celltrion Healthcare Co logo

091990 — Celltrion Healthcare Co News Story

0.000.00%
kr flag iconLast trade - 00:00
HealthcareAdventurousLarge Cap

Brief: Celltrion Usa Says U.S. FDA Approval Of Zymfentra For Treatment Of People With Inflammatory Bowel Disease

Oct 22 (Reuters) - 
  
    * CELLTRION USA - U.S. FDA APPROVAL OF ZYMFENTRA FOR
TREATMENT OF
PEOPLE WITH INFLAMMATORY BOWEL DISEASE

Source text for Eikon:  ID:nBw8TQJVka 
Further company coverage:  091990.KQ 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Celltrion Healthcare Co

See all news